Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company's products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in tablets, capsules, and eye drops forms. Jiangsu Jibeier Pharmaceutical Co., Ltd. was founded in 2001 and is based in Zhenjiang, China.
Frequently asked questions
What sector does Jiangsu Jibeier Pharmaceutical Co Ltd (688566) operate in?
Jiangsu Jibeier Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Jiangsu Jibeier Pharmaceutical Co Ltd (688566) current stock price?
As of the latest data, Jiangsu Jibeier Pharmaceutical Co Ltd stock price is CN¥27.72, with a previous close of CN¥27.97. Jiangsu Jibeier Pharmaceutical Co Ltd lost -CN¥0.25 in the last trading session, representing a -0.89% loss.
What is Jiangsu Jibeier Pharmaceutical Co Ltd (688566) current market capitalization?
Jiangsu Jibeier Pharmaceutical Co Ltd market cap is approximately 5.57 billion.
What is Jiangsu Jibeier Pharmaceutical Co Ltd (688566) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.06.
What is Jiangsu Jibeier Pharmaceutical Co Ltd (688566) Price-to-Earnings (P/E) ratio?
Jiangsu Jibeier Pharmaceutical Co Ltd current P/E ratio is 26.15.
Does Jiangsu Jibeier Pharmaceutical Co Ltd (688566) pay dividends?
No. Jiangsu Jibeier Pharmaceutical Co Ltd does not pay a dividend.
What is Jiangsu Jibeier Pharmaceutical Co Ltd (688566) beta (volatility) score?
Jiangsu Jibeier Pharmaceutical Co Ltd has a beta of 0.282, indicating lower volatility than the overall market.
